Development of an immunocytochemical assay to detect human CFTR expression following gene therapy

Development of an immunocytochemical assay to detect human CFTR expression following gene therapy

Bibliographic Details
Main Authors:	Davidson, H, Wilson, A, Gray, R, Horsley, A, Pringle, I, McLachlan, G, Gibson, J, Holder, E, Jones, L, Doherty, A, Coles, R, Sumner-Jones, S, Wasowicz, M, Manvell, M, Griesenbach, U, Hyde, S, Gill, DR, Davies, J, Collie, D, Alton, E, Porteous, D, Boyd, A
Format:	Conference item
Published:	2008

Similar Items

An immunocytochemical assay to detect human CFTR expression following gene transfer.
by: Davidson, H, et al.
Published: (2009)

Assessment of CFTR function after gene transfer in vitro and in vivo.
by: Griesenbach, U, et al.
Published: (2008)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
by: Alton, E, et al.
Published: (2012)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
by: Alton, E, et al.
Published: (2012)

OPTIMISATION OF MOLECULAR ASSAYS FOR CLINICAL TRIAL OF GL67A/PDNA DELIVERY TO NOSE AND LUNG OF CF PATIENTS
by: Sumner-Jones, S, et al.
Published: (2009)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
by: Gill, DR, et al.
Published: (2010)

Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
by: Davies, L, et al.
Published: (2008)

Development of highly sensitive TaqMan RT-PCR assays for quantifying vector mRNA in human samples
by: Sumner-Jones, S, et al.
Published: (2008)

Self-reactive CFTR T cells in humans: implications for gene therapy.
by: Calcedo, R, et al.
Published: (2013)

Detection of CFTR transgene mRNA expression in respiratory epithelium isolated from the murine nasal cavity.
by: Holder, E, et al.
Published: (2010)

Longevity of expression and levels of expression of gene therapy vectors using ovine air-liquid interface tracheal cells
by: Davidson, H, et al.
Published: (2007)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
by: Davies, J, et al.
Published: (2011)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
by: Davies, G, et al.
Published: (2011)

3-STEP TAQMAN RT-PCR: ULTIMATE MESSENGER RNA DETECTION SENSITIVITY FOR CF GENE THERAPY CLINICAL TRIALS
by: McCormick, D, et al.
Published: (2009)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
by: Alton, E, et al.
Published: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
by: Alton, E, et al.
Published: (2014)

TOXICOLOGY STUDIES IN SUPPORT OF THE UK CF GENE THERAPY CONSORTIUM'S MULTI-DOSE CLINICAL TRIAL
by: Griesenbach, U, et al.
Published: (2011)

Sendai virus-mediated CFTR gene transfer to the airway epithelium.
by: Ferrari, S, et al.
Published: (2007)

A randomized, double-blind, placebo-controlled trial of repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis
by: Alton, E, et al.
Published: (2015)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep
by: Alton, E, et al.
Published: (2013)

The safety profile of a cationic lipid-mediated cystic fibrosis gene transfer agent following repeated monthly aerosol administration to sheep.
by: Alton, E, et al.
Published: (2013)

Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments.
by: Emerson, M, et al.
Published: (2003)

Towards a first-in-human trial with a pseudotyped lentivirus
by: Alton, EW, et al.
Published: (2020)

Quantifying non-viral gene transfer by real-time PCR: a cautionary tale
by: Coles, R, et al.
Published: (2009)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
by: Alton, EWFW, et al.
Published: (2015)

Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
by: Pringle, I, et al.
Published: (2007)

Assessment of the air-liquid interface culture model as a tool to validate efficacy of a rSIV.F/HN-CFTR vector
by: Sergijenko, A, et al.
Published: (2021)

IMMUNOCYTOCHEMICAL STUDY OF THE BCL-2 GENE-PRODUCT
by: Pezzella, F, et al.
Published: (1990)

Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes.
by: Davies, L, et al.
Published: (2008)

Single cell assays for quantifying MRNA and protein during cystic fibrosis gene therapy trials
by: Sinadinos, A, et al.
Published: (2020)

Non-viral CFTR gene delivery to the lungs of Cystic Fibrosis patients
by: Hyde, S
Published: (2013)

Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
by: McLachlan, G, et al.
Published: (2011)

Gene therapy for respiratory diseases; progress and a changing context
by: Alton, EWFW, et al.
Published: (2020)

Low levels of CFTR gene transfer with F/HN pseudotyped lentivirus are sufficient to generate ion transport correction in airway cell cultures from cystic fibrosis patients
by: Sergijenko, A, et al.
Published: (2020)

Limitations of the murine nose in the development of nonviral airway gene transfer.
by: Griesenbach, U, et al.
Published: (2010)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
by: Hyde, S, et al.
Published: (2015)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
by: McLachlan, G, et al.
Published: (2004)

Optimizing aerosol gene delivery and expression in the ovine lung.
by: McLachlan, G, et al.
Published: (2007)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016)

Recombinant Sendai virus vector to evaluate vector distribution in a large animal model of lung gene transfer
by: McLachlan, G, et al.
Published: (2004)